Welcome to LookChem.com Sign In|Join Free
The company logo of CHINA MIGO INDUSTRIAL CO., LIMITED

CHINA MIGO INDUSTRIAL CO., LIMITED

Assessed supplier:
cooperative member
1Year
This supplier has been in lookchem for 1 year
Post Buying Request
In the shop
In the shop
In the station
Home>>Products>>USA Cagrilintide Overnight Cagrilintide Lyophilized Peptide Powder 99%

CHINA MIGO INDUSTRIAL CO., LIMITED

Assessed supplier:
cooperative member
1Year
This supplier has been in lookchem for 1 year

Country: China (Mainland)

Business Type:Trading Company

  • Mr.hugh

    Tel: 86-180-32025320

Mobile: 0086 18032025320

Tel: 86-180-32025320

Fax:

URL: http://www.yinaobiogroup.com/

Province/state: HONGKONG

City: HONGKONG

Street: RM D5 5/F KING YIP FACTORY BLDG NO. 59 KING YIP ST KWUN TONG HONG KONG

Contact Suppliers

Share to:

USA Cagrilintide Overnight Cagrilintide Lyophilized Peptide Powder 99%

CAS NO.1415456-99-3

  • FOB Price: USD: 100.00-100.00 /box Get Latest Price
  • Min.Order: 1 box
  • Payment Terms: T/T
Quality standards:
Quantity range

FOB price

  • 1-100 boxUSD $100 / box
Contact Supplier

Keywords

  • Cagrilintide Lyophilized Peptide
  • Cagrilintide
  • Peptide

Quick Details

  • ProName: Cagrilintide
  • CasNo: 1415456-99-3
  • Appearance: white powder
  • DeliveryTime: 3-5 DAYS
  • PackAge: BOX
  • Port: US
  • ProductionCapacity: 1000 box/Month
  • Purity: 99%
  • Storage: dry,clean
  • Transportation: USPS
  • LimitNum: 1 box

Superiority

US overnight delivery,safe and fast.

Details

Cagrilintide Lyophilized Peptide  operates through a unique mechanism as a triple agonist, targeting the GIP, GLP-1, and GCG receptors, with a strong emphasis on GIP receptor activation. This receptor interaction leads to a comprehensive approach to metabolic regulation, significantly impacting both glycemic control and weight loss. Below is an overview of the underlying mechanisms:

• Cagrilintide Lyophilized Peptide primary mechanism involves potent activation of the GIP receptor, which plays a vital role in appetite regulation by directly affecting the brain's satiety centers. This reduces hunger, cravings, and overall food intake.
• Through GLP-1 receptor activation, retatrutide supports glycemic regulation and enhances satiety. GLP-1 also slows down gastrointestinal motility and delays gastric emptying, leading to increased feelings of fullness after meals.
• Activation of the GCG receptor by retatrutide is believed to increase energy expenditure and promote fat oxidation, largely through metabolic actions in the liver. GCG receptor stimulation encourages fat breakdown and elevates metabolic rates. Additionally, it induces "beiging" of white fat, converting it into beige fat with thermogenic properties similar to brown fat, thereby boosting calorie burning and enhancing metabolism.  

Effect:
• Weight loss
• Helps lower blood sugar
• Slows gastric emptying
• Improved metabolism
• Muscle building
• Improve metabolic indicators such as blood glucose and blood lipids, and reduce the risk of cardiovascular disease.

RFQ